Phase
Condition
Obesity
Inflammation
Diabetes Prevention
Treatment
N/AClinical Study ID
Ages 18-65 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age 18-65 years
BMI greater than or equal to 30
Exclusion
Exclusion Criteria:
Currently pregnant or lactating
Type 2 diabetes
Use of oral anti-diabetes medications (with exception of Metformin for control ofPCOS)
Presence of known peripheral arterial or cardiovascular disease
Change in body weight (greater or equal to 3% within the past 3 months)
Recent use (within the four weeks prior to screening) of weight loss medicationsincluding but not limited to phentermine, sibutramine, orlistat, or over the counterweight loss products
History of an eating disorder or significant disordered eating behaviors such asbinging/purging, abuse of laxatives or diuretics
History of established renal or hepatic disease
History of prior bariatric surgery
Subjects who report routine tobacco use
Subjects on Angiotensin receptor blockers (medications such as but not limited tooAdicant, Losartan, Avapro, Diovan, Micardis, Teveten, Candesarten/thiazide,Ibesarten/thiazide, Valsartan/thiazide, Losarten/thiazide, Telmisarten/thiazide,Teveten/thiazide
Study Design
Study Description
Connect with a study center
Boston Medical Center
Boston, Massachusetts 02118
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.